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Abstract
Background: The question of how cells re-establish gene expression states after cell division is still poorly
understood. Genetic and molecular analyses have indicated that Trithorax group (TrxG) proteins are critical for the
long-term maintenance of active gene expression states in many organisms. A generally accepted model suggests
that TrxG proteins contribute to maintenance of transcription by protecting genes from inappropriate Polycomb
group (PcG)-mediated silencing, instead of directly promoting transcription.
Results and discussion: Here we report a physical and functional interaction in Drosophila between two members
of the TrxG, the histone methyltransferase ASH1 and the bromodomain and extraterminal family protein FSH.
We investigated this interface at the genome level, uncovering a widespread co-localization of both proteins at
promoters and PcG-bound intergenic elements. Our integrative analysis of chromatin maps and gene expression
profiles revealed that the observed ASH1-FSH binding pattern at promoters is a hallmark of active genes. Inhibition
of FSH-binding to chromatin resulted in global down-regulation of transcription. In addition, we found that genes
displaying marks of robust PcG-mediated repression also have ASH1 and FSH bound to their promoters.
Conclusions: Our data strongly favor a global coactivator function of ASH1 and FSH during transcription, as
opposed to the notion that TrxG proteins impede inappropriate PcG-mediated silencing, but are dispensable
elsewhere. Instead, our results suggest that PcG repression needs to overcome the transcription-promoting
function of ASH1 and FSH in order to silence genes.
Keywords: Drosophila melanogaster, Trithorax group (TrxG), Absent, small, or homeotic discs 1 protein (ASH1),
[Swiss-Prot:Q9VW15], Female sterile (1) homeotic protein (FSH), [Swiss-Prot:P13709], transcriptional regulation,
epigenetic gene control
Background
Gene expression programs specify diverse cellular identi-
ties during metazoan development, ultimately allowing
cells to form tissues or organs. The ability to maintain
expression states is critical, since inappropriate loss or
gain of gene activity may lead to developmental anomalies,
tissue dysfunction, or uncontrolled cell growth such as
cancer. The Trithorax group (TrxG) proteins and the
Polycomb group (PcG) proteins, originally identified in
Drosophila melanogaster but present in all higher eukar-
yotes, cooperate to sustain gene expression states by estab-
lishing and organizing information contained in the
chromatin template. This epigenetic information layer
assures the appropriate usage of the genetic blueprint,
according to the developmental history of any given cell.
TrxG proteins are required in order to maintain active
states. This was discovered because of their essential
trans-activating function for homeotic gene expression in
flies [1]. Despite their common implication in gene activa-
tion, the TrxG encompasses a variety of different bio-
chemical functions, ranging from chromatin remodeling
and histone modification to mediator complex subunits
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and transcription factors [2]. Genetically, the TrxG acts
antagonistic to the PcG of genes, which is essential for the
maintenance of repressed expression states.
The histone methyltransferases (HMTs) absent, small,
or homeotic discs 1 (ash1) and trithorax (trx) represent
histone modifying activities within the TrxG. Both
HMTs have attracted particular attention, because they
were considered to specifically counteract PcG silencing,
rather than being coactivators of transcription [3].
Studies of ASH1 enzymatic activity supporting this view
show that the histone modifications catalyzed by ASH1
disfavor Polycomb Repressive Complex 1 (PRC1) bind-
ing in-vitro, whereas association of SWI/SNF chromatin
remodeling complexes incorporating TrxG subunits
(BRAHMA, MOIRA) is preferred [4]. However, the
in-vivo relevance of this observation remains unclear,
since the targeting of PRC1 seems to primarily depend on
transcription factors and non-coding RNAs (ncRNAs) [5].
In addition, the assumed enzymatic specificity of ASH1
has lately been challenged by independent reports [6-8].
Alternative explanations on how ASH1 prevents PcG-
mediated silencing propose that ASH1 blocks PRC-activity
downstream to chromatin recruitment. A comparison of
the HOX gene Ultrabithorax (Ubx) in active and repressed
conditions supports this notion: PRC1 and PRC2 binding
patterns at the Ubx locus do not change between Ubx ON
or OFF states, whereas ASH1 is only located downstream
of the active Ubx promoter in embryonic discs [9]. In
addition, Ubx repression in the absence of ASH1 is
accompanied by the formation of an ectopic H3K27me3
domain, a mark associated with mature PcG-mediated
repression. Taken together, these data suggest that ASH1
actively prevents PcG silencing, however not by simply
impairing PRC1/2 recruitment to chromatin.
The functional relationship between PcG proteins and
ASH1 has been addressed on a genome-wide scale by two
recent ChIP-chip studies in Drosophila tissue culture cells.
Both investigations support the proposed anti-repressor
function of ASH1, either by showing that fully activated
PcG target genes miss typical marks of PcG-mediated
repression and instead become embedded in broad ASH1
domains [10], or by reporting that genes in ‘balanced’
states, characterized by simultaneous binding of PcG and
TrxG proteins, are transcriptionally active [10,11]. In both
studies a clear indication for a more general involvement
of ASH1 in transcription is missing. In accordance to this,
analysis of the wing imaginal disc transcriptome of ash1
mutant flies only identified few deregulated genes, again
supporting the idea that ASH1 is only needed at a subset
of developmental regulators, which need to be protected
from ectopic PcG repression [12].
Curiously, studies analyzing Ubx pattern formation in
embryonic disc stages suggest ASH1 to act as a general
transcription-promoting factor in analogy to what has
been shown for TRX. Briefly, ncRNAs, originating from
the bxd region upstream of the Ubx promoter, inhibit
Ubx expression in cis presumably by transcriptional
interference [13]. ASH1 localization downstream of the
bxd ncRNA promoters correlates with the onset of
ncRNA expression [14]. This behavior is reminiscent of
TRX, which was already shown to promote bxd ncRNA
expression, thereby silencing Ubx indirectly [15]. In the
reverse Ubx ON situation, ASH1 was found to be
enriched in the coding region of Ubx and a related GFP
reporter gene, but absent from bxd ncRNAs. Hence, the
correlation between ASH1 binding and transcriptional
activity at functionally diverse genes (ncRNAs, homeotic
selector, and reporter) is clearly indicative of a more
general involvement in transcription.
Another TrxG member, explicitly implicated in Ubx
regulation, is female sterile (1) homeotic (fs(1)h) [16,17].
Alleles of ash1 and fs(1)h show strong genetic interac-
tions with respect to Ubx activity. These interactions
have contributed to the proposal of a ‘trithorax gene set’
by Shearn, following the earlier idea of a repressive gene
cohort around Polycomb [18]. However, attempts to
link ASH1 and FSH on a biochemical level have not
been successful to date [17]. The fs(1)h gene products
belong to the BET family of proteins, named after their
characteristic arrangement of a tandem bromodomain
and the extra-terminal domain. Mammalian BET pro-
teins have been shown to serve as chromatin adapter
proteins by binding to acetylated histone tails and to
facilitate gene expression [19]. Lately, inhibition of BET
function has been identified as effective strategy to treat
poor-prognosis leukemia, multiple myeloma, and squa-
mous carcinomas [20-23]. How BET proteins contribute
to normal development and tissue homeostasis is still
poorly understood. Loss of function phenotypes in
model organisms having a single BET gene, such as
C. elegans BET-1 mutants and Drosophila fs(1)h mutants,
demonstrate that BET function is crucial for the estab-
lishment and maintenance of cell fates [16,24,25].
By purifying ASH1 from a stable Drosophila cell line, we
discovered a biochemical interaction between ASH1 and
FSH, as previously suggested from genetic studies in fly
mutants. In addition, we were able to show that both pro-
teins extensively co-localize on chromatin, especially at
sites bound by PcG complexes and gene promoters. The
observed co-localization at promoters is a hallmark of
active genes, but independent of gene type and function.
These findings are at odds with the prevalent model that
TrxG proteins function primarily as PcG-specific anti-
repressors, but are dispensable in the absence of PcG-
mediated repression. Our additional finding, that a set of
PcG-repressed genes displays ASH1, FSH, and TRX-C sig-
nals comparable to their active counterparts, further ques-
tions the anti-repressor hypothesis. In agreement with a
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general transcription promoting function, we could show
that BET inhibition in Drosophila tissue culture cells leads
to an immediate and widespread gene repression, as well
as delayed gene activation in reaction to environmental
stimuli.
Results
ASH1 interacts biochemically with FSH
In order to screen for ASH1-interacting proteins, we puri-
fied tandem-tagged ASH1 from a stable Drosophila cell
line and identified copurified proteins by tandem mass
spectrometry (MS/MS). Since no full-length cDNA was
available to generate bait expression constructs, we cloned
the ash1 coding sequence from S2 cells by assembling
four subcloned RT-PCR products (A-D) tilling the ASH1
open reading frame (ORF) from start to stop codon
(Figure 1A). We verified the resulting cDNA by transfect-
ing cells with ASH1-GFP fusion constructs. Immunoblot-
ting of cell lysates gave clearly detectable signals at the
expected molecular weight (MW) using antibodies (kind
gift from F. Sauer, UC Riverside) recognizing epitopes in
the N- and C-terminal part of ASH1 (Figure 1B). Sanger
sequencing showed that our cDNA contains a micro dele-
tion of the amino acids (aa) T1716-L1717 with respect to
[Swiss-Prot:Q9VW15] (Figure 1C). In spite of the two
missing amino acids it still encodes a fully functional pro-
tein, as demonstrated by rescuing the development of
ash1 null mutant flies (Steffen PA, Fonseca JP, Gänger C,
Dworschak E, Kockmann T, Beisel C, Ringrose L: Quanti-
tative in vivo analysis of chromatin binding of Polycomb
and Trithorax group proteins reveals retention of ASH1
on mitotic chromatin. Nucleic Acids Research 2013,
41:5235-5010.1093/nar/gkt217Available: http://eutils.ncbi.
nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id =
23580551&retmode=ref&cmd=prlinks.). An ASH1 ChIP-
chip profile has already been published by modENCODE
[11]. As a means of comparison we tested the immunor-
eactivity of the antibody (Q4177) used in their study
towards recognizing ASH1, which according to modEN-
CODE targets aa 1747-1846. To our surprise, we could
not detect signals corresponding to ASH1 by probing
whole cell und nuclear extracts (Figure 1D). Conversely,
control immunoblots of the same material faithfully
detected ASH1 using the ASH1-C antibody.
Based on our novel ASH1 cDNA we created a double-
affinity tagged expression construct under the control of
the inducible metallothionein promoter (Figure 2A).
Employing this vector construct we established a poly-
clonal S2-DRSC cell line, exhibiting inducible expression
of 3xFLAG-8xHIS-tagged ASH1 (FH-ASH1). Following
overnight induction of FH-ASH1, a three-step purifica-
tion as outlined in Figure 2B was performed. In the first
step, we captured tagged ASH1 from nuclear extract by
immobilized metal affinity chromatography (IMAC).
Captured FH-ASH1 was afterwards subjected to ion
exchange chromatography (IEX) and finally to FLAG-
affinity chromatography (FLAG-AC) for polishing. In
order to test if our purification scheme enriched pro-
teins in a bait dependent manner, we simultaneously
size-separated samples originating from induced and
non-induced cells. Silver staining visualized many pro-
tein bands exclusively present in the experimental sam-
ple, indicating a bait protein dependent enrichment
(Figure 2C).
MS/MS analysis revealed that FH-ASH1 was strongly
enriched in the experimental samples, but absent from
non-induced control samples (Figure 2D and Additional
file 1). The second most enriched protein was identified
to be female sterile (1) homeotic [Swiss-Prot:P13709],
encoded by the bona fide TrxG gene fs(1)h. Alternative
splicing of the primary fs(1)h transcript results in two
polypeptides: a short isoform denoted FSH-S, and a long
isoform denoted FSH-L. The second is a C-terminal
extension of its shorter relative. In order to approxi-
mately map the ASH1-FSH interaction, we co-expressed
the ASH1 fragments A-D in combination with FSH-S in
S2-DRSC cells. Immunoprecipitation of ASH1 A proved
to be sufficient to pull-down FSH-S (Figure 2F), suggest-
ing that the ASH1-interaction motive resides in the com-
mon N-terminal portion of the two splice products.
These results agree with the FSH peptide coverage from
our MS/MS analysis, since we also found peptides
belonging to the long isoform.
The unique domain arrangement identifies FSH as
members of the bromodomain and extraterminal (BET)
family. BET proteins are conserved from humans to lower
eukaryotes and have been shown to regulate gene expres-
sion by means of chromatin (Figure 3A). Their N-terminal
region contains a tandem bromodomain which attaches
BET proteins to acetylated histones. The tandem bromo-
domain is followed by the extraterminal domain of
unknown function, which is likewise present in all BET
proteins. The human BET family is comprised of BRD2, 3,
4, and BRDt. Drosophila FSH-L is closest to BRD4 and
BRDt, since all three proteins possess the C-terminal tail
extension. This tail is characterized by an unusual amino
acid composition, for instance including poly-glutamine
runs, and a C-terminal motive (CTM) at the very end of
the protein. FSH-S matches BRD2, 3, and BRD4-S with
respect to the missing tail region.
Large-scale analysis has shown that human bromodo-
mains cluster into eight families based on structure/
sequence similarity [26]. Family II is populated by the
BET-type bromodomains of BRD2, 3, 4, and BRDt. The
recent development of the highly potent, small molecule
inhibitor JQ1 allows selective inhibition of BET bromodo-
mains [20,27]. JQ1 specificity is explained by the excellent
shape complementarity with the acetyl-lysine binding
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cavity of BET-type bromodomains. We therefore asked, if
a similar selectivity can be expected in the context of the
Drosophila model system. Analogous to the situation in
humans, the fruit fly proteome contains several bromodo-
main proteins, which have been implicated in trans-
criptional control. We approached this question by a
phylogenetic analysis including human bromodomains of
known drug ability and their Drosophila homologs. We
found that FSH bromodomains are highly conserved with
respect to BRD proteins (approximately 80% identity,
>95% similarity), but well separated from bromodomains
of other families (Figure 3B). The superimposed human
JQ1 selectivity strongly argues in favor of a discriminating
drug ability of FSH. Structural alignments predict that
FSH bromodomains fold into the canonical left-handed
bundle of four a helices (aZ-aA-aB-aC) creating a hydro-
phobic acetyl lysine binding pocket (Figure 3C). All resi-
dues creating side-chain contacts to JQ1 have been found
conserved.
In order to assess whether JQ1 binding is competitive
with acetyl-lysine recognition, we performed histone pep-
tide pull-down assays. Binding of tetra-acetylated histone
H4 tail peptide to a purified BD1-BD2 fragment was
reduced to background levels in the presence of 10 µM
JQ1 (Figure 3D). We made similar observations using a
dual acetylated H3 tail peptide. Binding of none-purified
FSH-S, obtained by transfecting HEK293 cells, was like-
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Figure 1 Cloning and functional verification of a full-length ASH1 cDNA. (A) Map of Drosophila ASH1 protein indicating known domains
[SwissProt:Q9VW15]. Subcloned RT-PCR amplicons used for cDNA assembly are shown below. (B) ASH1-specific antibodies, raised against
epitopes residing in the N- and C-terminal portion of the protein, detect ASH1-GFP fusion products obtained by transfecting Drosophila cells
with expression constructs stated on top. (C) Sanger sequencing trace indicating missing amino acids T1716-L1717 in cloned ASH1 cDNA.
(D) Comparision of target and cross reactivity between the ASH1-specific antibodies ASH1-C and Q4177. Immunoblots of S2-DRSC derived whole
cell (Cell) and nuclear lysate (Nuc.) were prepared using the antibody dilutions given on top.
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conclude that JQ1 can be used to selectively target BET
function in Drosophila.
ASH1 and FSH co-localize on chromatin
Binding sites of ASH1 to chromosomes have been mapped
on a genome-scale in different Drosophila cell lines using
ChIP-chip methodology, while maps of FSH chromatin
occupancy are not available to date. In order to clarify
whether ASH1 and FSH also interact on chromatin, we
performed ChIP-seq experiments in S2-DRSC cells. In
addition, we contrasted their binding profiles with gen-


































































































































Figure 2 The TrxG protein FSH interacts biochemically with ASH1. (A) Map of inducible, tandem-tagged ASH1 expression construct used to
establish stable cell line. Amp: ampicillin resistance, bla: beta-lactamase promoter; FH: 3xFLAG-8xHIS tandem affinity tag; Hyg: hygromycin resistance;
MT: metallothionein promoter;, ori: origin of replication; P copia: copia promoter. (B) Outline of ASH1 purification scheme. ESI-MS/MS: electrospray
ionization tandem mass spectrometry; FLAG-AC: FLAG affinity chromatography; IEC: ion exchange chromatography; IMAC: immobilized metal affinity
chromatography. (C) FH-ASH1 dependent enrichment of proteins by purification scheme. Purified FH-ASH1 sample was size separated and silver
stained together with control sample. (D) Summary of mass spectrometry results; only the top two enriched proteins are shown (for complete
results see Additional file 1). (E) Maps of protein fragments used for coimmunoprecipitation experiments. (F) Coimmunoprecipitation of FSH-S
through ASH-A fragment. S2-DRSC cells were cotransfected with the indicated constructs, and whole cell lysates and precipitated proteins were
immunoblotted using the indicated antibodies.
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Figure 3 The BET family inhibitor JQ1 specifically targets FSH in Drosophila. (A) Conserved protein domain arrangement between BET
family proteins. The Drosophila BET family is exclusively represented by the long and short isoform of FSH. BD1: Bromodomain 1; BD2:
Bromodomain 2; CTM: C-terminal motive; ET: Extraterminal domain. (B) Assesment of BET inhibitor selectivity using a phylogenetic analysis of
Drosophila (blue) and human (black) bromodomains. BRD and FSH bromodomains form the BET clade highligted in gray. Notecolors of human
proteins indicate averaged temperature shifts upon binding of 10 µM JQ1 measured by differential scanning fluorimerty [20]. (C) Protein
sequence alignment of human and Drosophila BET bromodomains. Boxed residues reside in a helices as determined by structural analysis [26].
The high degree of sequence conservation suggests that FSH bromodomains shape into the typical left-handed bundle of four a helices (aZ, aA,
aB, aC) connected by loop regions. (D) Histone peptide pull-down assays using a purified, 6xHis-tagged BD1-BD2 fragment from FSH. 10 µM JQ1
effectively eliminates the interaction between acetlyted H4 (K5, K8, K12, K16) or H3 (K9, K14) peptides and the di-bromodomain fragment.
(E) Similar histone peptide pull-down assay using nuclear extract from HEK293 cells transfected with V5-tagged FSH-S.
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posterior sex combs (PSC), and the C-terminal TaspaseI
cleavage product of Trithorax (TRX-C), generated
previously by us [28]. We enriched for ASH1-bound chro-
matin by using the antibodies ASH1-N and ASH1-C.
FSH-bound chromatin was precipitated by antibody pre-
parations from immune sera kindly provided by Igor B.
Dawid (NICHD). Antibody ID166, raised against an
immunogen in the common N-terminal part of FSH, is
reactive against both FSH isoforms (Figure 4A, B). ID173
can be used to exclusively detect FSH-L. We verified anti-
body specificity by performing fs(1)h knockdown experi-
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Figure 4 FSH antibody preparation and validation of specificity. (A) Map of FSH protein isoforms indicating location of antigens ID166 and
ID173 used for rabbit immunization. BD1: bromodomain 1; BD2: bromodomain 2; CTD: C-terminal domain; ET: extraterminal domain. (B) Nuclear
extract from S2-DRSC cells was immunoblotted using FSH-specific antibodies; arrowheads indicate detected FSH isoforms. (C) S2-DRSC cells were
depleted from FSH isoforms using RNAi; immunoblotting of corresponding cell lysates using FSH-specific antibodies demonstrates the expected
specificity.
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Since ASH1 and FSH are known trans-activators of
homeotic gene expression, with central importance for
Ubx activation and maintenance [16,29], we first focused
on the bithorax complex (BX-C). We found that ASH1
and FSH co-localize at several discrete sites throughout
the BX-C (Figure 5A). The great majority of bound sites
coincide with known boundary elements, which divide the
gene cluster into regulatory domains [30]. But also known
cis-regulatory elements like the Ubx enhancers bx and bxd
show strong ASH1, FSH co-enrichments. Despite their
presence throughout the BX-C, all genes of the homeotic
cluster are silent in S2-DRSC cells. Considering their trans
activating function, this finding is contrary to expectation.
Our comparison with the additionally mapped PcG/
TrxG factors revealed that ASH1, FSH co-localization
throughout the BX-C is highly coordinated with PRC1
and TRX-C binding to chromatin (Figure 5A). We defined
PRC1-bound chromatin as genomic intervals co-enriched
for the PRC1 core subunits PC, PH, and PSC (see Material
and Methods for details). Again, this finding is rather sur-
prising since TrxG and PcG proteins implement antago-
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iab-8abx/bx bxd/pbx iab-2 iab-3 iab-4 iab-7iab-6iab-5
bxd Mcp Fab-6 Fab-7 Fab-8bx
Figure 5 ASH1 and FSH extensively co-localize on chromatin. Genome-wide maps of ASH1 and FSH chromatin occupancy were generated
using ChIP-seq. (A) Modified UCSC genome browser view of the bithorax gene cluster (BX-C) in S2-DRSC cells shows ASH1, FSH co-localization
at TRX-C, PRC1-bound sites. The position of regulatory iab regions (capped bars) and cloned PREs (solid boxes) are indicated above track area.
ASH1 and FSH tracks show coverage profiles calculated from aligned ChIP-seq reads; solid boxes of PRC1 track (black) depict regions significantly
co-enriched for the PRC1 core subunits PC, PH, and PSC; the TRX-C track (yellow) displays intervals enriched for the C-terminal fragment of TRX.
FlyBase gene models and non-coding RNAs are shown below track area. (B) FSH-specific immunostainings of Drosophila salivary gland
chromosomes. (C) ASH1 and FSH peaks are closer to TSS then expected by chance. Graph shows empirical cumulative density functions (ECDFs)
for the distance between identified ASH1, FSH peaks and the closest TSS. For comparison, the ECDFs calculated form shuffled peak intervals are
plotted as dashed lines. (D) Accumulation of ASH1, FSH ChIP-seq signal around TSS. Graph displays normalized read coverage for ASH1, FSH
averaged over 1-kb windows centered at known TSS.
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investigate these phenomena on a genome scale and found
that the observed co-localization is not restricted to the
homeotic clusters. In total, we identified about 10,700
regions enriched for ASH1 and about 8,800 occupied by
FSH. By using the combined chromatin maps for PC, PH,
and PSC we identified 800 sites bound by PRC1 with high
confidence. More than 80% of these sites are shared with
ASH1 and the same is true for FSH (Table 1). In agree-
ment with our ChIP-seq data, immunostaining of polytene
chromosomes visualized hundreds of FSH-bound regions
(Figure 5B).
We previously showed that gene promoters are major
recruitment sites for TrxG/PcG proteins [28]. We therefore
examined the spatial relationship between transcription
start sites (TSS) and ASH1, FSH bound genomic regions,
by measuring the distance between ASH1, FSH peaks and
the closest annotated TSS (see Materials and methods for
details). As shown in Figure 5C, a majority of peaks are clo-
ser to TSS then expected by chance, in fact >50% are
within 1 kb of distance (random peak distribution was
modeled by shuffling peaks along chromosomes, P value
<2.2 × 10-16). In order to further fine-map ASH1, FSH
binding relative to TSSs, we calculated binding profiles
across non-overlapping 1 kb windows centered at TSSs.
For both proteins we obtained unimodal coverage distribu-
tions with a maximum very close to the aligned TSS posi-
tions (Figure 5D). These localization profiles demonstrate
that ASH1 and FSH prefer binding nearby TSSs.
In summary, ASH1 and FSH binding to chromatin is
strongly correlated and seems to happen at many sites in
dividing cells, as well as post mitotic tissue. Our high-reso-
lution analysis suggests that these sites coincide with the
starting point of transcription. But also intergenic ele-
ments bound by the PRC1 complex attract ASH1 and
FSH.
ASH1 and FSH co-localization is a hallmark of active
genes
The fact that ASH1 and FSH both bind to promoter
regions, prompted us to examine the relationship between
gene activity and ASH1, FSH binding in more detail. We
did this by inspecting genomic regions containing a mix of
silent and transcribed genes. A representative example is
shown in Figure 6A. In agreement with our previous
results, ASH1 and FSH ChIP-seq signals peak closely to
TSSs. A striking difference in ASH1, FSH localization was
observed when we compared active and silent genes: All
active genes - determined by detectable mRNA expression
(RNA-seq) and high H3K4me3 levels at the promoter
(ChIP-seq) - displayed prominent ASH1 and FSH peaks
close to their TSS. Silent genes, by contrast, lacked these
characteristic signals.
We further examined the observed correlation between
transcription and ASH1, FSH localization to promoters, by
comparing metagene profiles of genes grouped according
to their expression level. We refer to a metagene profile as
the mean read density over gene bodies scaled to a
common length. As reference point for the analysis, we
included our H3K4me3 ChIP-seq data, because this chro-
matin modification is known to be highly correlated with
gene expression. In analogy to H3K4me3, the total amount
of ASH1, FSH ChIP-seq signal correlated with the magni-
tude of expression (Figure 6B). The maximum ASH1, FSH
signal intensity collapsed with the TSS position when
inspecting profiles for active gene bins. To rule out the
possibility that our analysis was confounded by a sequen-
cing bias at highly expressed loci, we inspected metagene
profiles for our input sample using identical binning, but
could not detect indications for such systematic errors
(data not shown).
Coverage profiles suggested that ASH1 and FSH nor-
mally bind close to the TSS of active genes, but are absent
from promoter distal parts of the gene body. Deviating
from this canonical observation, we found signals within
gene bodies at a subset of active genes: predominantly,
these genes fall into the category of intron-rich, active
genes. Similar observations have been described earlier
[11]. However, the same study did not pick-up the correla-
tion between ASH1 binding and transcription at intron
poor genes. Representative examples illustrating the differ-
ence between intron-rich and intro-poor active genes are
shown in Figure 6C. At the active, intron-rich Dad gene,
ASH1 and FSH signals seem to spread along the gene
body. In contrast, the active intron-poor gene Cyp12c1
does not show signals distal to the TSS. Here, the ASH1,
FSH signal is tightly restricted to the promoter proximal
region.
Combined TrxG/PcG binding patterns predict the
regulatory state of genes
Genetic experiment using double-mutants for TrxG and
PcG genes, suggested that TrxG proteins such as ASH1
are primarily needed to prevent inappropriate PcG-
mediated silencing, instead of having a general function
Table 1 Overlap between TrxG/PcG ChIP-seq peaks in S2-
DRSC cells.
Fraction (%) of query peaks overlappinga
reference peaks
Query Peaks (n) ASH1 FSH PRC1 TRX-C
ASH1 10,748 - 82 6 21
FSH 8,824 92 - 7 25
PRC1 800 87 82 - 83
TRX-C 2,608 94 92 24 -
Table lists pair-wise, directional overlap between ASH1, FSH, PRC1, and TRX-C
ChIP-seq peaks identified using MACS (see Materials and methods for details).
aPeak intervals enriched for the query protein overlap by ≥1 bp with at least
one interval occupied by the reference protein.
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during transcriptional activation [3]. Since our data
clearly favor the second possibility, we decided to exam-
ine the combinatorial patterns of TrxG/PcG proteins
found at chromatin. The fact that all our ChIP-seq
experiments have been carried out using identical
experimental procedures/materials ensures high compar-
ability across chromatin maps.
In brief, we identified combinatorial binding patterns by
fitting a three component sparse Gaussian mixture model
(sGMM) to the ChIP-seq enrichments at promoters (see
Materials and methods for details). This approach is
related to k-means clustering. Our choice to solely focus
on the promoter region was based on our previous finding
that all of the TrxG/PcG factors mapped by our laboratory
preferred binding close to the TSS. In addition, this special
constrain allows for an intuitive correlation between ChIP
signals and gene expression.
The fitted sGMM partitioned genes as follows: class 1
genes do not show enrichments for any of the consid-
















































































Figure 6 ASH1, FSH co-localization correlates with gene expression. (A) Modified UCSC genome browser view of a representative genomic
region containing silent (blue arrowheads) and active genes (red arrowheads). ASH1 and FSH tracks show data as described before; H3K4me3
track displays read coverage profile for H3K4me3 ChIP-seq experiment; mRNA track contains coverage profile obtained by short-read sequencing
of mRNA (RNA-seq). FlyBase gene models are depicted below track area; arrowheads indicate direction of transcription; vertical dashed lines
mark TSS positions. (B) Graphs show normalized ChIP-seq read density profiles across genes grouped according to their expression level (zero,
low, medium, and high). (C) Comparison of ASH1, FSH ChIP-seq signals across intron-rich and intron-poor, active genes. Tracks display data as
described before. Intron-rich, active genes show strong ASH1, FSH signals inside gene bodies in contrast to their intron-poor counterparts. Both
gene classes share promoter proximal signals.
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Figure 7 TrxG/PcG binding profiles are predictive for gene regulatory states. A sparse Gaussian Mixture Model (sGMM) emitting class
assignment (1, 2, and 3) was fitted to ChIP-seq enrichment data for ASH1, FSH, TRX-C, PC, PH, and PSC. Normalized enrichments relative to Input
were calculated for the 1-kb window centered at known TSS. (A) Pairs plot of the fitted model in selected dimensions; each plotting symbol
represents a TSS window (class 1 = circle, class 2 = triangle, class 3 = plus sign); color-coding of plotting symbols indicates corresponding gene
expression level (see color key for details). Numbered ellipses denote mean and variance of each class in the plotted dimensions. (B) Class 1
genes are characterized by the absence of TrxG/PcG proteins at the promoter. Class 2 and class 3 genes are cobound by ASH1 and FSH, in
addition class 3 genes display strong PRC1 and TRX-C enrichments. Heat map plotting class means (columns) over all model dimensions. Row
clustering indicates proteins showing correlated changes between classes. (C) Class 1 and class2 genes are mostly inactive, while class 2 genes
get transcribed. Boxplots display distribution of gene expression within each sGMM class. Graphs show density estimates for gene expression
and H3K4me3 modification (1-kb window) within each sGMM class compared to all genes (total). (D) Class 2 signal density and mRNA signal
density show strong spatial correlation across chromosomes. Plot shows kernel density estimations for class 2 predictions and discretized mRNA
signal (log2 FPKM cut-off = 2.5) in 1-kb windows tiling chromosomes.
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B). Judged by mRNA production the great majority of
class 1 genes is not expressed and accordingly lacks the
‘active’ histone modification H3K4me3 (Figure 7C). In
total, approximately 55% of all analyzed genes fall into
this class. Therefore, we simply termed this class ‘Inac-
tive’. Class 2 genes display strong signals for ASH1 and
FSH at their promoters together with intermediate
TRX-C enrichments (Figure 7A, B). These genes are
clearly transcribed, matching our previous results that
ASH1 and FSH presence at promoters correlates with
gene expression (Figure 7C). We named this group, con-
taining approximately 43% of all analyzed genes, the
‘Active’ class. A representative gene belonging to the
active cluster is shown in Figure 8A. In agreement with
its cluster assignment Spf45 displays strong ASH1 and
FSH ChIP-seq signals at the transcription start site. The
RNA-seq and H3K4me3 ChIP-seq profiles reflect high
expression as expected for a splicing factor.
Class 3 genes are characterized by extraordinary high
signals in the PC, PH, PSC, and TRX-C dimensions, but
their promoters are also occupied by ASH1 and FSH,
notably to the same extend as class 2 genes (Figure 7A,
B). Approximately 1.5% of all analyzed genes belong to
this class. Inspection of their activity showed undetect-
able expression with very few exceptions (Figure 7C). In
combination these findings suggested that class 3 con-
tains genes being actively repressed by the PcG. We
therefore termed class 3 ‘PcG-repressed’. A representa-
tive example is given in Figure 8B. The H15 TSSs is
bound by ASH1, FSH, PRC1, and TRX-C. According to
RNA-seq and H3K4me3 signals it is completely
repressed. This observation makes sense, since H15
encodes for a transcription factor involved in cardioblast
cell fate commitment.
To answer the question how accurately our classification
predicts gene expression in a simplified binary manner
(ON or OFF), we labeled genes according to their mRNA
score as silent or transcribed (log2 FPKM cut-off = 2.5)
and inspected label frequencies within classes 2 and 3.
The cut-off was chosen according to the bimodal distribu-
tion of expression values as shown in Figure 7C. For the
active class we found that approximately 88% of the genes
are expressed according to our cut-off. In case of the PcG-
repressed class the inverse is true, meaning approximately
85% of examined genes are silent. Taken together, these
frequencies demonstrate that our unsupervised clustering
approach has identified patterns that can be used to pre-
dict simplified gene expression states with high accuracy.
In contrast to former attempts to predict gene expression
based on chromatin binding profiles, we did not use any
cotranscriptional histone modifications [31,32].
Our results suggest that the class 2 TrxG/PcG signa-
ture is a good predictor for active promoters. In order
to confirm this, we simply divided the genome into
overlapping tiles of 1 kb and examined the correlation
between RNA production and class 2 affiliation based
on our fitted model (see Materials and methods for
details). The genome-wide correlation coefficient of 0.7
indicates that the appearance of class 2 entities and
transcription are strongly coupled. To visualize the spa-
tial correlation we co-plotted smoothed density esti-
mates for mRNA production and class 2 predictions
along chromosomes (Figure 7D). As suggested by the
overall correlation coefficient, both estimates are highly
correlated.
Pharmacologic inhibition of FSH function causes global
down-regulation of gene expression
Our chromatin profiling suggests that ASH1 and FSH
operate as global transcriptional co-activators irrespective
of gene type and function. In order to test this hypothesis,
we perturbed FSH binding to chromatin by using the BET
inhibitor JQ1 [20]. To test the effect of FSH inhibition on
gene expression, we treated exponentially growing S2-
DRSC cells with JQ1 for 1, 2, 4, and 20 h and monitored
gene expression changes over time by RNA-seq. At 4 h
post JQ1 addition approximately 2,500 genes were down-
regulated to <50% of their initial level (Figure 9A, C, and
D). In sharp contrast, only very few genes reacted to the
treatment by elevating transcription. Most genes that were
down-regulated at 4 h were already repressed at earlier
time points and stayed repressed during the monitored
time frame, suggesting a fast and sustainable reduction of
gene activity by JQ1 treatment (Figure 9C). Some genes
were progressively repressed over time and some reverted
to their initial steady-state level at 20 h. The last observa-
tion might indicate that these genes find ways to compen-
sate the loss of FSH activity. An alternative explanation
could be the propagation of secondary effects in the regu-
latory network. Plotting gene expression fold-changes ver-
sus FSH enrichments at promoters visualized that down-
regulated genes are bound by FSH in the absence of drug
treatment (Figure 9B).
We next asked how the withdrawal of FSH from chro-
matin affects the localization of ASH1. We addressed
this question by treating S2-DRSC cells with JQ1 for 4 h
and monitoring the chromatin association of both pro-
teins to a selection of active promoters using ChIP-
qPCR. In agreement with the previous result the treat-
ment induced a graduate loss of FSH from active pro-
moters. At most examined sites, FSH is reduced to
approximately 50% of the initial level, but there are also
insensitive loci, which show no or minor changes upon
BET inhibition (Figure 9F). The reduction of FSH occu-
pancy at promoters is accompanied by a limited loss of
ASH1 from the same locations. This correlation might
suggest that FSH helps to stabilize the interaction of
ASH1 with target promoters. Alternatively, altered
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ASH1 levels at promoters simply reflect reduced
transcription.
The reported experiments focused on the relevance of
FSH function for steady-state transcription. In addition,
we wondered whether FSH is needed for the effective
activation of gene expression in response to stimuli. In
order to test this, we exposed S2-DRSC cells to lipopo-
lysaccharide (LPS), which is known to trigger the
expression of genes coding for antimicrobial peptides
(AMPs). Cells pretreated with JQ1 showed a slower
accumulation of the AMP transcripts CecA1 and CecB
in response to LPS induction (Figure 9E).
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Figure 8 Comparison of Active and PcG-repressed genes. (A) Genome browser view of the class 2 gene Spf45; data are displayed as
described before. (B) Genome browser view of the class 3 gene H15. Both genes are co-bound by ASH1/FSH, whereas PRC1 and TRX-C are
selectively enriched at the repressed H15 promoter.
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Figure 9 Small molecule inhibition of FSH induces widespread down-regulation of gene expression. S2-DRSC cells were treated using the
BET inhibitor JQ1 for 1, 2, 4, and 20 h. For each time-point relative gene expression changes were monitored by mRNA-seq. (A) MA plot
showing gene expression changes after 4 h of JQ1 treatment. Red color highlights genes showing a significant differential expression (adjusted P
value <0.05). (B) Scatterplot of gene expression changes versus FSH enrichments at promoters. (C) Heat map illustrating expression changes over
time for all genes >2 times up- or down-regulated after 4 h of treatment. Colors indicate regularized log2 fold change according to color key.
(D) Bar plots summarizing the number of up- and down-regulated genes for each time point. (E) JQ1 pretreatment of S2-DRSC cells dampens
LPS-inducible gene expression. CecA1 and CecB transcript levels were measured using qPCR. (F) Removal of FSH from active promoters by JQ1
treatment is accompanied by a loss of ASH1. Bar charts show ChIP signals measured by qPCR. Error bars indicate STDs of two biological
replicates. The TSS of CG6280 is neither occupied by ASH1, nor by FSH according to ChIP-seq analysis (represents background signal).
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RNAi-mediated knockdown of FSH induces minor gene
expression changes with repespect to
pharmacological treatment
Our expression profiling of JQ1-treated Drosophila cells
showed a fast and widespread down-regulation of tran-
scription. In contrast to mammalian cell culture systems,
Drosophila offers the opportunity to knockdown BET
function by targeting a single gene. We therefore decided
to compare the transcriptional response between FSH
knockdown and small molecule inhibition. RNAi effec-
tively depleted FSH isoforms from dsRNA-treated S2-
DRSC cells within 3 days (Figure 10A). By targeting either
both isoforms, or exclusively FSH-L, we intended to par-
tially deconvolute their contribution to transcriptional
control. This is of special interest, since the CTM connects
FSH-L to the pTEF-b pathways, whereas FSH-S lacks this
protein interaction domain [37]. For both knockdowns we
monitored gene expression changes using RNA-seq. Sub-
sequently we identified differentially expressed genes by
comparing FSH knockdown conditions (two replicates
each) with control treatments (eGFP specific dsRNA). For
both knockdowns only few genes showed >2-fold differen-
tial expression (Figure 10B). In addition, we observed com-
parable numbers of up- and down-regulated genes.
Overall, the selected targeting of FSH-L still showed a
weaker effect on transcription, than a complete depletion
of both isoforms.
We therefore conclude that FSH knockdown does not
induce the drastic transcriptional changes that we observed
by small molecule inhibition. We believe that the deviating
results are caused by the limited time resolution inherent
to RNAi experiments, which in general do not allow mea-
suring the primary response of the gene regulatory network
(see Discussion for details).
Discussion
Experiments using double mutants of the TrxG genes
ash1 and fs(1)h demonstrated a strong genetic interaction,
whereas attempts to demonstrate a biochemical interac-
tion remained unsuccessful so far. By purifying tagged
ASH1 from a stable cell line, we discovered the missing
physical connection between the two transcriptional acti-
vators. Indeed, the study by Chang et al. [17] attempting
to demonstrate this interaction by FSH-S purification
might have failed because of inappropriate purification
conditions, or deviating starting material with respect to
our study.
In line with our interaction proteomics results we show
that ASH1 and FSH extensively co-localize on chromatin.
Both proteins jointly target active gene promoters irre-
spective of gene function. Intron-rich, active genes tend
to display ASH1and FSH signal distal to the TSS. Con-
trasting to our results, two recently published ChIP-chip
studies have reported that ASH1 forms broad domains
encompassing fully activated PcG target genes, or is
bound at TSSs maintained in a ‘balanced’ state [10,11].
This balanced state is distinguished by the co-existence
of PcG and TrxG proteins as well as production of full-
length mRNA. The investigators deduced from these
results that ASH1 cannot be a general transcriptional
activator, but instead functions as specific antagonist of
PcG-mediated repression. This conclusion was backed
up by earlier genetic experiments showing that ASH1
function is dispensable for Ubx activation in the absence
of PcG-mediated repression [3]. Our ASH1 chromatin
maps unequivocally identify ASH1 binding to genes as
being highly predictive for transcriptional activity. In
addition, we cannot confirm that this behavior is in any
sense restricted to a defined set of target genes, such as
genes under PcG-control. On the contrary, we detected
strong ASH1/FSH signals at housekeeping genes, for
instance Cyp12c1 (Figure 6C) and Spf45 (Figure 8A). We
could extend the list by further components of cell meta-
bolism like ribosomal subunits or histone genes (not
shown). These findings strongly argue in favor of a general
involvement of ASH1 and FSH in transcription. Support
for this notion comes from a study examining the chroma-
tin localization of ASH1L in a panel of human cell lines.
By applying ChIP-qPCR the authors could show that
ASH1L associates with the transcribed region of all active
genes examined [33]. In addition, the distribution of
ASH1L in transcribed chromatin was found to resemble
that of H3K4me3. Our genome-wide, high resolution
mapping study in fly cells comes to similar conclusions.
Missing ASH1 signals at active transcription units have
been used to argue against a general involvement of
ASH1 in transcription. Our analysis of the S2-DRSC
chromatin landscape suggests that previous mapping stu-
dies failed to detect these signals and therefore jumped to
conclusions based on incomplete evidence. A reasonable
explanation for the enhanced sensitivity of our mapping
study might be the employment of next-generation
sequencing technology instead of microarrays. Direct
comparison of ChIP-chip and ChIP-seq has shown that
ChIP-seq generally produces profiles with better signal-
to-noise ratio and allows detection of more and narrower
peaks [34]. Still, the lower measurement sensitivity/
resolution is not sufficient to explain the magnitude of
differences. Our investigation of the antibody Q4177,
generated on behalf of the modENCODE consortium,
suggests that poor target reactivity of the immunoreagent
might be the major explanation for missed ChIP signals
in the study by Kharchenko et al. [11] (Figure 1D).
Schwartz et al. [10] however partially relied on the same
antibodies as we did.
Regarding the absolute number of reported binding
sites we would like to note that we used a peak detection
algorithm (MACS) that was developed to map human
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transcription factor (TF) binding sites in ChIP-seq data
(see Materials and methods for details). Sequence specific
TFs typically generate sharply restricted, Gaussian-like
ChIP-seq signals. Therefore, the algorithm was ideally
suited to detect ASH1, FSH signals at TSS. At the same
time, it tends to break up more widely distributed signals,
like the ones we described for intro-rich active genes,
into closely spaced peak clusters. Hence, the absolute
number of peaks reported in this study does not reflect
the number of functional elements bound by ASH1 and
FSH in a one-to-one correspondence.
The second major argument against a general involve-
ment of ASH1 in transcription was provided by the Ubx
activity in ash1/E(z) double-mutant mitotic clones, located
in- and outside of the endogenous Ubx expression domain
[3]. In our opinion, this observation does not directly con-
tradict the co-activator hypothesis favored by our data. It
is conceivable that ASH1 and other TrxG proteins only
modulate the transcriptional output, rather than being
absolutely required for transcription. The incomplete, sto-
chastic loss of Ubx activity in embryonic tissues devoid of
ASH1 protein already argues against such a strict require-
ment [3,29], and studies of heat shock response have
already demonstrated a transcription modulating function
for TRX [35]. The latter finding is especially intriguing,
because trx/E(z) double-mutant clones show Ubx reactiva-
tion patterns similar to their ash1/E(z) counterparts [3].
Our unsupervised clustering of genes according to their
combined TrxG/PcG binding profiles identified a class of
transcription units with concurrent high PRC1 and TrxG
enrichments at the promoter. In contrast to the ‘balanced’
state introduced by Schwartz et al. [10], these genes do
not generate a transcript. We argue that the existence of
this ‘PcG-repressed’ class provides additional evidence
against the anti-repressor hypothesis. Instead, we favor the
idea that fully installed PcG-repression needs to overcome
the general co-activator function of TrxG proteins. We
have previously identified Polycomb (Pc) interacting pro-
teins by in-vivo biotinylation tagging [36]. Unexpectedly,
this approach revealed FSH to interact with Pc in the Dro-
sophila embryo. Our current analysis of FSH chromatin
occupancy now shows that PRC1 and FSH co-localize at
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Figure 10 Comparison of global expression changes by fs(1)h knockdown by RNAi and BET inhibitor treatment. (A) Western blots
indicate efficient FSH protein depletion in S2-DRSC cells after 3 days of dsRNA-treatment. Numbers above lanes mark samples from two
biological replicates done in parallel. (B) Differential expression analysis by RNA-seq. The upper row shows MA plots comparing gene expression
in FSH knockdown cells (DRSC29017 and FSH-L) and cells treated with control dsRNA (eGFP). The lower row shows volcano plots of the same
data, illustrating the selection of differentially expressed genes according to a combined P value, fold change cut-off. Blue lines indicate the
chosen two-fold gene expression cut-off. The red lines illustrates the 5% significance level according to the adjusted P value <0.05 computed
using DESeq’s multiple testing procedure. The number of genes passing both selection criteria are given on top.
Kockmann et al. Genome Biology 2013, 14:R18
http://genomebiology.com/2013/14/2/R18
Page 16 of 24
repressed promoters and intergenic gene regulatory ele-
ments, although they are known to fulfill antagonistic
functions. Mechanistically this might suggest that PRC1
silences genes by blocking the elongation-promoting func-
tions of FSH, for instance via the pTEF-b pathway. In the
light of these deliberations it is sensible that PcG-bound
promoters do show elevated levels of promoter proximal
pausing, as we have reported earlier [28]. Future experi-
ments using defined in-vitro transcription systems in con-
junction with reconstituted PRC1 and FSH might shed
light on the mechanistic details of this interaction.
Our data provides evidence that FSH promotes the tran-
scriptional activity of genes. How might this work at a
mechanistic level? The human FSH-L homolog BRD4 pro-
teins contain a conserved pTEF-b interacting domain in
the very C-terminus, which is sufficient to directly recruit
pTEF-b to target genes [37]. Following recruitment, pTEF-
b triggers the transition from early elongation (promoter-
proximal pausing) to productive elongation by phosphory-
lating Serine 2 residues in the RNA polymerase II CTD
[38]. In addition, pTEF-b has been shown to phosphory-
late DISF and NELF which releases the repressive factor
NELF and converts DISF into a positive elongation factor.
Studies in Drosophila have shown that pausing represents
a widespread gene regulatory strategy. Our data are in line
with this possible mechanism, since displacement of FSH
leads to a widespread down-regulation of transcription. A
recent study has shown that BRD4 is also able to directly
phosphorylate Serine 2 of the Pol II CTD [39]. A kinase
activity has also been demonstrated for FSH-S [17]. Using
a defined in-vitro transcription system, it has been shown
that the human BRD2, BRD3 render nucleosomes marked
by acetylation permissive to the passage of elongating
RNA polymerase II, thereby bypassing FACT requirement
[40]. Taken together, FSH might therefore support the
passage of two central checkpoints of the transcription
cycle: first, it might be critical to release RNA polymerase
II into productive elongation by initiating CTD phosphor-
ylation and pausing factor release. Second, it potentially
removes nucleosomal barriers in front of the elongating
polymerase. In addition, the loss of ASH1 from promoters
after FSH removal might indicate that the ASH1-FSH
interplay stabilizes the association of ASH1 with chroma-
tin. Additional evidence for cooperation between ASH1
and FSH during gene activation is provided by our recent
study, applying regression models in order to predict gene
expression based on chromatin binding profiles. In this
quantitative modeling framework, the two proteins form
an interaction pair [31].
Our JQ1 treatment of Drosophila tissue culture cells
provides evidence, that transcriptome homeostasis is
heavily affected by small molecule inhibition of BET pro-
teins. This observation corresponds to our FSH chroma-
tin map, since we observed a high correlation between
FSH localization and gene activity. Exactly the same
results have recently been described with respect to
BRD4 in human CD4+ T cells and ES cells. ChIP-seq
revealed that BRD4 localizes to active promoters and
enhancers, and that expression levels are strongly corre-
lated with BRD signal intensity [41]. BRD4 profiles across
active human promoters display that BRD4 binds at the
TSS. Here we show the same for FSH in Drosophila cells.
The degree of correlation between BRD4 localization and
transcriptional activity even encouraged the authors to
predict that ‘BRD4 could potentially be used as a gen-
ome-wide hallmark of active or poised genes’. Our gene
clustering according to TrxG/PcG promoter binding sup-
ports this idea. Interestingly, our clustering into active
and PcG-repressed genes parallels the human classifica-
tion into active and poised genes in a sense that poised
genes are occupied by BET proteins, but do not produce
mRNA. Disruption of BRD4 chromatin binding by JQ1 in
CD4+ T cells resulted in reduced expression of more
than a thousand genes in CD4+ T cells [41]. Again, we
have reporter similar observation using JQ1 treatment in
fly cells. In contrast, knockdown of FSH did not result in
comparable transcriptional repression. We argue that the
deviating results are due to the different natures of the
treatment. Small molecule inhibition happens almost
instantaneously. By monitoring the system in a time-
resolved manner it is possible to untangle primary and
secondary effects. Effective depletion of target proteins by
RNAi can only be achieved within time scales of days.
Therefore RNAi experiments rather disclose a novel
steady-stead of the reduced network than primary effects.
Similar thoughts should be considered when interpreting
expression profiles obtained from zygotic mutants, since
maternal gene products are present during development.
Like in RNAi-mediated knockdowns it becomes impossi-
ble to define a time point that corresponds to functional
null situation, but is not governed by secondary effects.
A recent study in erythroid cells shows, that BRD3 is
recruited to target promoters by reading an acetyl mark
on the transcription factor GATA1, instead of being pri-
marily dependent on histone acetylation [42]. The concen-
tration of FSH signals around TSSs fits the idea that
acetylated transcription factors might also contribute to
BET protein recruitment in flies.
Conclusions
There is substantial evidence that TrxG proteins play glo-
bal roles in transcription. In the future it will be interest-
ing to find out, why this group of proteins genetically
scores as being important for the maintenance of the
active state of HOX genes, or in other words, what discri-
minates them from other factors in functional proximity
to RNA polymerase. More mechanistic insight how TrxG
complexes are connected to transcription machinery will
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be necessary to answer this question. It might indeed
turn out that TrxG complexes ‘are among those that
have emerged as being important for maintenance for a
relatively uninteresting reason e.g., because even rela-
tively subtle changes in the expression of Drosophila
HOX genes cause homeotic transformations’ [1].
Materials and methods
Generation of ASH1 expression construct and stable
cell line
The ash1 coding sequence was PCR-amplified from S2 cell
derived cDNA in four overlapping parts (A-D) using the
primers listed in Additional file 2, Table 1. Subsequently,
each PCR product was inserted into the pENTR/D-TOPO
vector for the Gateway Cloning System as outlined in the
manufacturer’s instructions (pENTR/D-TOPO cloning kit,
Invitrogen). The full-length ash1 coding sequence was
reassembled from these primary clones by three direc-
tional subcloning steps, utilizing the restriction sites indi-
cated in Figure 1A. Sanger sequencing confirmed that the
derived full-length cDNA matches the ASH1 SwissProt
entry [Swiss-Prot:Q9VW15] with the exception of codons
T1716 and L1717, which seems to be absent from ash1
mRNA in S2 cells (Figure 1C).
In order to generate the ASH1 expression construct out-
lined in Figure 2A, the Hygromycin resistance cassette
(AccI/SapI fragment taken from pCoHygro plasmid, Invi-
trogen) was inserted into the AccI/SapI-cut pMT/V5-His
A vector backbone (Invitrogen). In addition, the sequence
between EcoRV/HpaI encompassing MCS to SV40 polyA
was replaced by the EcoRV/PmeI-excised fragment from
pAFW (Drosophila Gateway Collection, available through
DGRC). In a subcloning step, this fragment was previously
modified by inserting the 8xHis-TEV coding sequence
(generated by hybridizing the oligo nucleotides listed in
Additional file 1, Table 4 into the AgeI site between
3xFLAG and gateway cassette. Finally, the ash1 coding
sequence was transferred to the inducible pMT/FHW
HygRes expression vector by standard gateway cloning
according to manufacturer’s instructions (Invitrogen).
In order to generate the stable cell line, S2-DRSC cells
grown in Schneider’s medium incl. 10% FCS were lipo-
transfected using pMT/FH-ASH1 HygRes according to
standard Effectene protocols (Quiagen). Two days post-
transfection transformants were selected by Hygromycin B
addition to the growth medium (500 µg mL−1) and pas-
saged for 4 weeks in the presents of the selecting agent.
FH-ASH1 purification and identification of co-purified
proteins
Expression of tandem tagged ASH1 was induced by add-
ing 500 µM copper(II) sulfate to the growth medium for
approximately 16 h. Afterwards cells were scraped in ice
cold PBS, pelleted by low speed centrifugation (500 × g)
and suspended in N buffer (15 mM HEPES pH 7.4, 10%
Sucrose, 0.5 mM EGTA, 60 mM KCl, 15 mM NaCl,
Complete Protease Inhibitors EDTA-free). Resuspended
cells were lysed by adding Triton X-100 to 0.5% (vol./
vol.) for 10 min. Next, nuclei were separated from cyto-
plasm by passing the lysate through a sucrose cushion
(20% sucrose in N buffer) and washing nuclei twice in
N buffer. In order to extract nuclear proteins, washed
nuclei were transferred to lysis buffer (15 mM TRIS pH
7.4, 300 mM NaCl, 1 mM MgCl, 0.1 mM EDTA,
20 mM Imidazole, 0.1% NP-40, 10% Glycerol, Complete
Protease Inhibitors EDTA-free) and sonicated in the Bior-
uptor (Diagenode) for five to 10 cycles (20 s ON/40 s OFF,
high power setting). Afterwards nuclear extract was trea-
ted with 150 u mL-1 Benzonase (Novagen) for 10 min and
cleared by ultra-centrifugation (100,000 × g for 1 h).
In order to capture 8xHis tagged ASH1 protein, nuclear
extract was diluted in IMAC buffer A (50 mM TRIS pH
7.4, 20 mM Imidazole, 100 mM NaCl, 10% Glycerol, Com-
plete Protease Inhibitors EDTA free), adjusted to 300 mM
NaCl, and loaded onto a Ni-Sepharose column (HisPrep
FF 16/10, GE Healthcare) connected to a FPLC system
(AKTApurifier, GE Healthcare). Afterwards non-specifi-
cally bound proteins were eliminated by washing the col-
umn with 4% IMAC buffer B (50 mM TRIS pH 7.4,
500 mM Imidazole, 100 mM NaCl, 10% Glycerol, Com-
plete Protease Inhibitors EDTA-free) and bound proteins
were eluted at 60% buffer B. Eluate fractions were probed
for FLAG-tagged ASH1 by western blot, pooled accord-
ingly, and adjusted to 100 mM NaCl by diluting pooled
material in IEX buffer A (50 mM TRIS pH 7.4, 10% Gly-
cerol, Complete Protease Inhibitors EDTA-free). Next,
material was loaded onto an anion exchange column
(SOURCE 15Q 4.6/100 PE, GE Healthcare) and washed
using 10% IEX buffer B (50 mM TRIS pH 7.4, 1 M NaCl,
10% glycerol, Complete Protease Inhibitors EDTA-free).
Bound material was eluted by a linear gradient from 10 to
100% IEX buffer B over 10 column volumes again moni-
toring FLAG-tagged ASH1 by western blot. ASH1-
containing eluate fractions were pooled, adjusted to 0.05%
NP-40 and incubated overnight with 100 µL FLAGM2
agarose (Sigma). Next, agarose was washed several times
using TBS, 0.05% NP-40 and transferred to Mobicol spin
columns for eluting bound material by 200 µg mL-1
3xFLAG peptide (Sigma) dissolved in wash buffer. Eluted
proteins were precipitated in 20% TCA (w./vol.) by high-
speed centrifugation, washed using 10% TCA and ice-cold
Acetone, and air-dried. Next, dried proteins were resus-
pended in reduction buffer (500 mM TRIS pH 8.6, 6 mM
Guanidin-HCl), reduced and alkylated by subsequent addi-
tion of TCEP (100 mM) and Iodoacetamid (250 mM),
respectively. Then proteins were digested in digestion buf-
fer (50 mM TRIS pH 7.4, 5 mM CaCl2, 2% ACN) by addi-
tion of 0.1 mg mL-1 Trypsin Gold (Promega). Tryptic
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peptides were separated using online reverse-phase chro-
matography and electrosprayed into a LTQ Orbitrap
Velos tandem mass spectrometer (Thermo Scientific). MS
spectra were recorded at 60,000 R and most intense pep-
tide ions were selected for CID fragmentation and record-
ing of product ion spectra. MS/MS spectra were matched
against UniProtKB release 2011.08 using the Mascot
search engine (Matrix Science), assuming the digestion
enzyme Trypsin and up to one missed cleavage. Mascot
was searched with a fragment ion mass tolerance of 0.5 Da
and parent ion tolerance of 5 ppm. Iodoacetamide deriva-
tive of cysteine was specified in Mascot as a fixed modifica-
tion. S-carbamoylmethylcysteine cyclization (N-terminus)
of the n-terminus, deamidation of asparagine and gluta-
mine and oxidation of methionine were specified in Mascot
as variable modifications. Scaffold 3.3.1 (Proteome Soft-
ware) was used to validate MS/MS based peptide and pro-
tein identifications. Peptide identifications were accepted if
they could be established at >95.0% probability as specified
by the Peptide Prophet algorithm [43]. Protein identifica-
tions were accepted if they could be established at >99.0%
probability and contained at least three identified peptides.
Protein probabilities were assigned by the Protein Prophet
algorithm [44]. For complete results see Additional file 1.
Generation of FSH expression constructs and co-
immunoprecipitation
The FSH-S coding sequence was PCR-amplified from the
Drosophila Gold Collection clone LD26482 (available
through DGRC) using primers listed in Additional file 2,
Table 1. The PCR-product was afterwards inserted into
pENTR/D-TOPO as outlined in the manufacturer’s
instructions (pENTR/D-TOPO cloning kit, Invitrogen). In
order to generate the HA-tagged expression construct the
FSH-S ORF was transferred to pAHW (Drosophila Gate-
way Collection, available through DGRC) using standard
gateway cloning. In addition, the ASH1 fragments A-D
were transferred to the 3xFLAG-tagged pAFW plasmid
(Drosophila Gateway Collection). For co-immunoprecipi-
tation S2-DRSC cells were co-transfected with pair-wise
combinations of pAH-FSH-S and pAF-ASH1 A-D by
using standard Effectene (Qiagen) lipotransfection proto-
cols. Two days post-transfection whole cell lysates were
prepared using RIPA lysis buffer and tagged ASH1 frag-
ments were immunoprecipitated by FLAGM2 antibody
(Sigma) coupled to Protein G Dynabeads (Invitrogen).
Precipitated proteins were eluted by boiling Dynabeads at
70°C in 1xLDS sample buffer (Invitrogen) for 10 min.
Immunoblotting of eluted proteins and nuclear extracts
was conducted using Novex TA 3-8% gradient gels and
iBlot transfer system according to manufacturer’s instruc-
tions (Invitrogen). For immunodetection of HA-tagged
FSH-S HA.11 antibody (Covance) was used at 1:2,000 in
PBS, 0.1% Tween-20, 5% dry milk powder followed by
anti-mouse IgG-HRP (GE Healthcare) at 1:10,000 in PBS,
0.1% Tween-20, 5% dry milk powder. ECL detection of
proteins was conducted using ECL substrate and X-ray
films from GE Healthcare.
FSH knockdown by RNAi
PCR products serving as templates for in-vitro transcrip-
tion were generated from pENTR/D-TOPO FSH-S using
T7 recognition sequence flanked primers listed in Addi-
tional file 2, Table 3. PCR amplicons DRSC18778,
DRSC29017 were taken from the DRSC reagent data-
base [45]. The FSH-L specific amplicon was designed
using E-RNAi [46]. Purified PCR products were tran-
scribed to dsRNA and cleaned using the MEGAscript
RNAi Kit according to manufacturer’s instructions
(Ambion). RNAi was carried out according to standard
bathing protocols in 6-well plate format (Drosophila
RNAi Screening Center, Harvard Medical School) by
adding 15 µg of dsRNA to each well before platting S2-
DRSC cells in serum free Schneider’s medium and star-
ving cells for 30 min.
FSH antibody preparation
Serum from rabbits immunogenized with FSH-specific
antigens was kindly provided by Igor Dawid (National
Institute of Child Health and Human Development). The
antigen used for rabbit ID166 corresponds to the XbaI/
PstI fragment from clone e1.20 and the antigen injected
into rabbit ID173 is derived from the EcoRI/HindIII frag-
ment of clone e4.1, both described in [16]. Generation of
b-Gal/FSH-S fusion constructs, protein expression, and
immunization was done in the laboratory of I. Dawid as
described in [17]. Immunoglobulin G purification from
rabbit serum using Protein A Sepharose CL-4B (GE
Healthcare) was carried out as described in [47], Basic
Protocol 2. In order to validate the antibody specificity, we
performed immunoblotting of S2-DRSC lysates depleted
of FSH protein by RNAi as described before (Figure 4C).
In order to reduce high background signals, FSH-specific
antibodies were diluted in high-salt PBS (300 mM NaCl),
1% Tween-20, 5% dry milk powder.
Quantification of LPS-inducible gene expression under
JQ1 treatment
One hour before lipopolysaccharide (LPS) was added to the
growth medium S2-DRSC cells were pretreated using
either JQ1 or DMSO as described before. After LPS addi-
tion (5 µg mL-1) cells were lysed at indicated time points
using Trizol (Invitrogen). In order to quantify the tran-
scriptional response of known LPS-inducible genes (CecA1,
CecB) total RNA was extracted, reverse transcribed (First
Strand cDNA Synthesis kit, Fermentas), and TURBO
DNase (Ambion) treated as outlined in the manufacturer’s
instructions. Quantification of cDNA was done by qPRC
Kockmann et al. Genome Biology 2013, 14:R18
http://genomebiology.com/2013/14/2/R18
Page 19 of 24
using SYBR Green chemistry and primers listed in Addi-
tional file 2, Table 2 on the LightCycler 480 thermocycler
(Roche Diagnostics). For calculating target gene levels rela-
tive to the house keeping gene ATPsyn-Cf6 the ΔΔct
method including efficiency correction was used. Determi-
nation of ct values was done by calculating the second deri-
vative maximum of the SYBR green signal.
Histone peptide pull-down assays
The V5-tagged FSH-S expression construct was created by
transferring the FSH-S ORF from pENTR/D-TOPO to
pcDNA6.2/V5-DEST using gateway cloning according to
manufacturer’s instructions (Invitrogen). Nuclear extract
from HEK293 cells lipotransfected with pcDNA6.2/V5-
FSH-S was prepared 2 days post-transfection using Active
motif’s Nuclear Extract Kit as outlined in the correspond-
ing manual. For histone peptide pull-down assays 10 µL of
nuclear extract (equivalent to 2 × 106 cells) was diluted in
binding buffer (50 mM TRIS pH 8.0, 150 mM NaCl,
5 mM MgCl, 0.1% NP-40, Complete Protease Inhibitors
EDTA-free) and incubated with 20 µg Acetyl-Histone H4
(Lys5, 8, 12, 16) peptides (Millipore, Catalog # 12-379) in
the presence or absence of 1 µM JQ1. Afterwards biotiny-
lated peptides were precipitated using Streptavidin Dyna-
beads M-270 (Invitrogen) and washed several times in
binding buffer. Peptide-bound protein was eluted by boil-
ing Dynabeads in 1xLDS sample buffer (Invitrogen) and
immunoblotted together with nuclear extracts as described
for coIP assays. V5-tagged protein was detected using anti-
V5 antibody (Invitrogen) at 1:5,000 in PBS, 0.1% Tween-
20, 5% dry milk powder, followed by anti-mouse IgG-HRP
(GE Healthcare) at 1:10,000 in PBS, 0.1% Tween-20, 5%
dry milk powder, ECL substrate, and Hyperfilm (GE
Healthcare).
The BD1-BD2 coding sequence was PCR amplified from
the vector LD26482 and cloned into pNIC28-Bsa4 (Struc-
tural Genomics Consortium) applying ligation indepen-
dent cloning (LIC). The resulting plasmid was used to
express 6xHis-tagged BD1-BD2 in BL21(DE3) E. coli. Cell
lysate was prepared by sonicating cells in 20 mM Tris-HCl
pH 8.0, 1 mM PMSF, 1mg/ml Lysozyme, 0.05% Triton
X-100 for 15 min (30 s ON/30 s OFF) in a water bath
sonicator followed by high speed centrifugation. BD1-BD2
was purified from cleared lysate by IMAC on Ni-NTA
Superflow (Qiagen) deploying an imidazole step-gradient
(50, 100, 150, 250 mM). BD1-BD2 containing eluate frac-
tions were monitored by Coomassie-stained SDS-PAGE
and concentrated in 25 mM HEPES pH 8.0, 150 mM Nacl
using 10 NMWL centrifugal filter devices (Millipore). For
BD1-BD2 pull-downs approximately 3 µg of purified pro-
tein was incubated with 35-40 µM of histone tail peptide
in 25 mM HEPES pH 8.0, 150 mM NaCl in the presence
or absence of 10 µM JQ1. After 1 h of incubation at 4°C
biotinylated peptides were captured on streptavidin
magnetic beads and washed three times in binding buffer.
Precipitated proteins were eluted by boiling magnetic
beads in 1x LDS buffer. Eluted proteins and input samples
were immunoblotted using anti His-probe (H-3) HRP
(Santa Cruz Biotechnology) and standard ECL reagents.
Analysis of protein binding to chromatin by ChIP-seq
Chromatin immunoprecipitation followed by next-
generation sequencing (ChIP-seq) was essentially done
as described in [28] using formaldehyde cross-linked
chromatin from 2.5 × 107 S2-DRSC cells per ChIP. In
order to assure data comparability across ChIP-seq
experiments, all chromatin samples were taken from the
same chromatin batch. This chromatin batch is identical
to the one we used previously to generate ChIP-seq data
for PC, PH, PSC, and TRX-C.
ASH1-bound chromatin was enriched using two anti-
body preparations provided by the lab of F. Sauer (Univer-
sity of California, Riverside). Anti-ASH1-N recognizes an
antigen located in the amino-terminus of ASH1, while
the anti-ASH1-C specific antigen resides in the carboxy-
terminal portion of the protein. Both polyclonal antibodies
have been raised in rabbits. Since different dsRNA treat-
ments of S2-DRSC cells did not induce detectable ASH1
knockdown (data not shown), we investigated antibody
specificity by expressing ASH1-GFP fusion proteins in S2-
DRSC cells and immunoblotting of cell lysates (Figure 1B).
FSH-bound chromatin was enriched by the anti-FSH and
anti-FSH-L antibody preparations described above.
Sequencing libraries were prepared from 10 ng of
immunoprecipitated DNA using the ChIP-seq DNA Sam-
ple Prep Kit (Illumina), including size selection of pream-
plified fragments on agarose gels (200 bp +/- 30 bp). For
quality control, the size distribution of the final libraries
was assayed on the Agilent BioAnalyzer 2100 using High
Sensitivity DNA microfluidic chips. Each library was
sequenced for 36 cycles in a single-end run on the Gen-
ome Analyzer IIx (Illumina). Sequencing yielded approxi-
mately 20 × 106 quality filtered reads per library (Illumina
Chastity Filter), corresponding to a mean genome cover-
age of approximately 5x. Short reads (36 bp) were aligned
to the Drosophila reference genome (BDGP Release 5)
using Bowtie 0.12.7 and the following parameters: -n 2, -m
20, -k 1, –best [48]. Since anti-ASH1-N and anti-ASH1-C
target the same protein isoform, we decided to merge the
corresponding alignments prior to downstream analysis.
The same was done for the FSH-specific alignments, since
we could not detect mayor differences between these data-
sets (data not shown). Merging and indexing of alignments
was done using SAMtools 0.1.9 [49]. Regions showing sig-
nificantly enriched read coverage compared to input chro-
matin (also referred to as ‘peaks’) were calculated using
MACS 1.4.0 and the following parameters: band width,
300; model fold, 10 to 30; P value cut-off, 1 × 10-5 [50].
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Read coverage profiles were calculated from aligned reads
by shifting and extending reads according to the fitted
MACS models. The distance calculation between peak
intervals and TSS was carried out using the R/Bioconduc-
tor package ChIPpeakAnno (Release 2.9) and basic R func-
tions [51]. Interval based co-localization analysis was done
by comparing MACS peak lists with BEDtools 2.10.0 [52].
The compilation of high-confidence PRC1 sites was con-
structed by intersecting peak lists for PC, PH, and PSC
using BEDtools. PC, PH, and PSC specific peak list were
compiled using MACS on our previously published PcG
ChIP-seq dataset available through NCBI’s Gene Expres-
sion Omnibus [53]. Metagene profiles were created using
the R/Bioconductor package GenomicRanges (Release
2.9). In short, based on alignments, coverage vectors for
each chromosome were calculated. From these vectors, all
subvectors were extracted that correspond to ORFs of
known protein coding genes having well separated TSSs
(min. distance to next TSS = 1 kb). Next, kernel density
functions were calculated from these subvectors and
sampled at 500 equally spaced points in order to create
read density estimates at positions relative to ORFs.
Finally, the position-wise mean densities were calculated
after grouping genes according to expression level and
plotted along relative positions in order to obtain meta-
gene profiles. In order to create promoter profiles, cover-
age vectors spanning all non-overlapping 1-kb windows
centered at known TSS were calculated. Position-wise
mean read coverage was calculated and plotted along the
relative position to obtain coverage profiles. Quality-fil-
tered reads, MACS peak lists, and coverage profiles have
been deposited in NCBI’s Gene Expression Omnibus and
are accessible through GEO Super Series accession num-
ber GSE36450 [54].
Gene expression analysis by RNA-seq
For JQ1 treatment of exponentially growing S2-DRSC
cells lyophilized JQ1 was dissolved in DMSO (10 mM)
and added to the culture medium at a concentration of
10 µM. RNA extraction from S2-DRSC cells was done
using Trizol reagent according to manufacturer’s
instruction for adherent cells (Invitrogen). Barcoded
sequencing libraries were prepared from 4 µg of total
RNA according to Illumina’s TruSeq protocol including
polyA-enrichment, mixed in equal proportions and
sequenced together on a single HiSeq2000 lane (Illu-
mina) using a 50-cycle single-end run.
Alignments of RNA-seq reads were generated using
the splice-junction-aware aligner TopHat [55] and Dro-
sophila gene models originating from Ensembl release
64 (default parameters). All reads uniquely mapping to
gene models were counted by the HTSeq-count script
(HTSeq developed by Simon Anders, EMBL Heidelberg)
and the count statistic was forwarded to bioconductor
package DESeq [56]. Since the standard size factor esti-
mation of DESeq produced inappropriately adjusted
counts, an alternative normalization procedure was
applied, assigning the 100 most abundant genes in the
control condition as normalization index. The principle
behind this strategy is comparable to qPCR normaliza-
tion using a house keeping gene index.
Demultiplexed RNA-seq reads and raw gene counts
have been deposited in NCBI’s Gene Expression Omni-
bus and are accessible through GEO Super Series acces-
sion number GSE36450 [57].
Computation of ChIP-seq enrichments at promoters
ChIP-seq and input reads were counted on 1kb win-
dows +/- 500 bp around N = 13,254 unique TSS
defined in the ensGenes table of the UCSC browser
with the pysam python module. Subsequently, the rela-
tive frequencies pi = Xi/m of ChIP counts Xi on TSS i
were normalized by a rescaling of the library size m to
maximize the number of TSS where the relative ChIP
frequency was identical to that of the corresponding
value qi = Yi/n in the input experiment. The symbol Yi
denotes the read count in interval i in the input
experiment and n the input library size. For each TSS
and ChIP experiment, a binomial likelihood ratio test
was computed testing the null hypothesis pi = qi versus
the alternative pi ≠ qi, and the sum over all TSS of the
resulting P values was maximized numerically over m.
Normalized enrichments were then computed as pi/qi.
Data normalization and enrichments were computed
in R.
Gene clustering according to TrxG/PcG ChIP-seq profiles
at promoters
The sparse Gaussian mixture model (sGMM) is a prob-
abilistic mixture model of multivariate Gaussian distri-
butions, in which the covariance matrices are estimated
under an L1-penalty favoring sparse solutions [59]. The
model was fitted to the set of logarithmic TrxG/PcG
ChIP-seq enrichments at known transcription start sites
defined above.
Let xi Î Rn be a vector of ChIP-seq enrichments from
different antibodies in TSS window i and j(xi; µ, Σ)
denote the density of a multivariate Gaussian with mean
μ and covariance Σ. An sGMM with m mixture compo-
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The model parameters πk, μk, and Σk were estimated
iteratively by the expectation maximization (EM) algo-
rithm, where in each step the inverse covariance matrices
Σk
-1 are computed from the weighted empirical covar-
iances Sk = Ni=1γ
i
k(x
i − μk)T(xi − μk) with the graphical
LASSO algorithm [60,61]. Here γ ik = πkφ˜k(x
i)/tπtφ˜t(xi)
denote the posterior probabilities of observation xi belong-
ing to class k, and N is the number of TSS. For r = 0, the
sparse GMM is equivalent to a regular Gaussian mixture
model with full covariance matrices, while for large values
of r one enforces a GMM with diagonal covariance
matrices, similar to the k-means algorithm. Clustering of
the TSS is achieved by the Bayes estimate assigning xi to
the class k that maximizes gki. This procedure also allows
for predicting the classes of new TSS by computing their
class probabilities according to Eq. (1).
A three-component sGMM was fitted to normalized
ChIP enrichment values as stated above. The unpenalized
sGMM had a tendency to overfit the third component
into the shoulder of the cluster of highly enriched Ash1/
Fsh TSS, instead of separating highly enriched PRC1 TSS.
Under a penalization of r = 0.5, the model yielded three
distinct classes with diagonal covariance matrices, except
for a cluster of correlated high PRC1 enrichments. These
classes overlapped 94% with the results of a k-means clus-
tering, confirming the robustness of the sGMM estima-
tion. TSS clusterings were computed in R.
Additional material
Additional file 1: ESI-MS/MS analysis overview. Spreadsheet contains
analysis results of ESI-MS/MS experiments.
Additional file 2: DNA oligonucleotides used in this study. Tables
listing oligos used for PCR, molecular cloning, and qPCR.
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